Overview

To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
Phase:
Phase 2
Details
Lead Sponsor:
Zeria Pharmaceutical
Treatments:
Z 338